FDA-Approved PET Agents
| Agent | ||
| Name | NDA sponsor | Original approval date |
| Fluoride F-18 (sodium fluoride F-18) | GE Healthcare | February 24, 1972 |
| Cardiogen-82 rubidium Rb 82 generator | Bracco | December 29, 1989 |
| Fludeoxyglucose F18 | Downstate Clinic | August 19, 1994 (epileptic foci only) |
| Fludeoxyglucose F18 | Weill Cornell | August 5, 2004 (glucose metabolism) |
| Ammonia N13 | Feinstein | August 23, 2007 |
| Amyvid florbetapir F18 | Avid Radiopharmaceuticals | April 6, 2012 |
| Choline C 11 | Mayo Clinic | September 12, 2012 |
| Vizamyl flutemetamol F18 | GE Healthcare | October 25, 2013 |
| Neuraceq florbetaben F18 | Piramal | March 19, 2014 |
| Axumin fluciclovine F18 | Blue Earth Diagnostics | May 27, 2016 |
| NETSpot Ga 68 dotatate | AAA | June 1, 2016 |
NDA = new drug application.
Nomenclature follows FDA-approved label (http://accessdata.fda.gov).